[HORMONAL INHIBITION OF OVULATION. METHODS, INDICATIONS, SIDE-EFFECTS, RESULTS].
D003270:Contraceptive Agents; D003276:Contraceptives, Oral; D004412:Dysmenorrhea; D004715:Endometriosis; D004997:Ethinyl Estradiol; D005260:Female; D006801:Humans; D007246:Infertility; D007247:Infertility, Female; D009277:Nandrolone; D010060:Ovulation; D011276:Pregnanediol; D011293:Premenstrual Syndrome; D011374:Progesterone; D011372:Progestins; D014116:Toxicology
D003270:Contraceptive Agents; D003276:Contraceptives, Oral; D011372:Progestins; D004997:Ethinyl Estradiol; D011374:Progesterone; D009277:Nandrolone; D011276:Pregnanediol
CONTRACEPTIVES, ORAL; DYSMENORRHEA; ENDOMETRIOSIS; ETHINYL ESTRADIOL; NANDROLONE; PREGNANEDIOL; PREMENSTRUAL TENSION; PROGESTATIONAL HORMONES; PROGESTERONE; STERILITY, FEMALE; TOXICOLOGIC REPORT
HORMONALE OVULATIONSHEMMUNG. METHODEN, INDIKATIONEN, NEBENWIRKUNGEN, ERGEBNISSE.